BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Feb 8, 2016
Clinical News

Entolimod: Phase II started

BioCentury | Oct 20, 2014
Product Development

Walking the toll road

Why investors have started placing bets on toll-like receptors again
BioCentury | May 19, 2014
Company News

Cleveland BioLabs other news

BioCentury | Jan 27, 2014
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | May 16, 2013
Distillery Therapeutics

Indication: Cancer

BioCentury | Nov 19, 2012
Clinical News

Cleveland BioLabs preclinical data

Items per page:
1 - 10 of 56